Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression. - Tu, Chia-Mu; Lin, Meng-Hsuan; Liu, Chih-Peng; Chen, Shih-Ta; Liu, Chun-Min; She, Meng-Ping; Wang, Yu-Cheng; Wang, Hsiang-Ching; Chang, Yuan-Chia; Chang, Li-Wen; Lo, Yo-Wen; Lin, Min-Xun; et al. (Scientific Reports, 2025)